Published in Cancer Weekly, March 29th, 2005
"Cyclooxygenase-2 (COX-2) expression is mediated by constitutive nuclear factor NF-kappa B. The aim of this study was to investigate the association between the germline alteration of the NF-kappa B binding site of COX-2 and the risk of developing various types of human cancers," researchers in South Korea report.
"Using PCR and DNA sequence analysis, we performed a hospital-based case-control study involving various types of human cancers, namely cervical, breast, lung, and bladder cancer," described S. Kang and colleagues, Seoul National...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.